could glp-1 be the next mental health drug GLP-1s may improve some outcomes in addition to lowering body weight The Unexpected Mental Health Effect

Wong MG, Perkovic V, Chalmers J, et al

Liraglutide's approval for weight management indicated a shift towards using GLP-1 agonists explicitly for this purpose, highlighting their dual benefits in controlling blood sugar and reducing weight

Aging Population in Europe: Europe's population is increasingly aging, contributing to an increased incidence of type 2 diabetes and related illnesses

For individuals with BMI above 40 or 50, the difference between 20% and 28% weight loss can be the difference between still being classified as obese and reaching a healthy weight range

Sci Rep 11:22063

Retrieved July 10th, 2024 from Novo Nordisk (n.d.)